Skip to content
AnalystLens

Omega Healthcare Investors Annual Report, Year Ended Dec 31, 2019

Filing Date
Filed February 28, 2020
Period End
December 31, 2019
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jul ’16Jul ’16
  2. Material agreement8-K · Feb ’19Feb ’19
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 10-K filed February 28, 2020. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. ("Omega") is a REIT whose core business is financing long-term healthcare, with a focus on skilled nursing facilities (SNFs) and assisted living facilities (ALFs), largely under triple-net leases and fixed-rate mortgages.

As of December 31, 2019, its portfolio included 987 healthcare facilities in 40 states and the U.K., operated by 71 third-party operators, with investments of approximately $9.8 billiona. Total operating revenues rose to $928.8 million in 2019 from $881.7 million in 2018, and net income was $351.9 million versus $293.9 million. Nareit FFO was $640.0 million compared with $587.2 million in 2018.

Growth in 2019 was driven by roughly $1.7 billionb of new investments, including the merger with MedEquities Realty Trust ($661 million), the $757 million Encore portfolio acquisition, and a $104 million U.K. joint venture investment. These were funded in part by a $500 million 3.625% senior notes offering due 2029, a forward equity sale settled for approximately $295.9 million, and at-the-market and dividend reinvestment issuances. Common dividends paid totaled $564.1 million, with $2.65 declared per share for 2019.

Debt was about $5.2 billionc, representing approximately 54.5% of total capitalization. Investors should weigh several risks disclosed in the filing: operator financial stress, with Daybreak facing impairments and Agemo rent deferrals; ongoing Medicaid and Medicare reimbursement pressures, including the proposed Medicaid Fiscal Accountability Rule and the fiscal 2021 budget proposal; a DOJ civil investigative demand related to Lakeway Hospital; and a pending appeal of a securities class action that was dismissed in 2019. Impairments on real estate were $45.3 million in 2019, and the company reported 2019 gains on asset sales of $55.7 million.

Key Highlights

  1. Total operating revenues increased to $928.8 million in 2019, up from $881.7 million in 2018, and net income rose to $351.9 million from $293.9 million.
  2. Nareit FFO reached $640.0 million in 2019 compared with $587.2 million in 2018.
  3. The company completed about $1.7 billion of new investments in 2019, including the $661 million MedEquities merger, the $757 million Encore portfolio acquisition, and a $104 million U.K. joint venture interest.
  4. The portfolio at December 31, 2019 comprised 987 facilities in 40 states and the U.K., operated by 71 third-party operators, with real estate investments of approximately $9.8 billion.
  5. Common dividends paid in 2019 totaled $564.1 million, with $2.65 per share declared, and the Board declared $0.67 per share payable February 14, 2020.
  6. Debt totaled $5.2 billion, approximately 54.5% of total capitalization, and the company issued $500 million of 3.625% senior notes due 2029 in September 2019.
  7. Impairments on real estate properties were $45.3 million in 2019, primarily on 23 facilities being exited, and Daybreak is being restructured with expected rent of $15 million to $20 million annually after restructuring.

Financial Statements

FY2019 against FY2018

Line itemFY2019FY2018Change
Revenue$928.83M$881.68M+5.3%
Operating Expenses$641.50M$610.29M+5.1%
Operating Income$551.75M$497.59M+10.9%
Interest Expense$208.72M$192.46M+8.4%
Net Income$341.12M$281.58M+21.1%
EPS (Basic)$1.60$1.41+13.5%
EPS (Diluted)$1.58$1.40+12.9%
Shares Outstanding (Basic)213.40M200.28M+6.6%
Shares Outstanding (Diluted)222.13M209.71M+5.9%

Frequently Asked Questions

  1. How did Omega's revenue and earnings change in 2019?

    Total operating revenues were $928.8 million in 2019, up $47.1 million from 2018, led by a $36.7 million increase in rental income tied to the MedEquities merger, the Encore acquisition, and facility additions. Net income was $351.9 million, compared with $293.9 million in 2018, and Nareit FFO was $640.0 million versus $587.2 million.

  2. What major acquisitions did Omega complete in 2019?

    Omega completed the $661 million acquisition of MedEquities Realty Trust through merger on May 17, 2019, the $757 million Encore portfolio of 60 facilities on October 31, 2019, a $104 million 49% interest in a U.K. joint venture, and the purchase of three SNFs for about $25 million.

  3. What are the main risks to Omega's rental income?

    The filing identifies operator financial distress and bankruptcy, reductions in Medicare and Medicaid reimbursement, and state-level Medicaid pressures, particularly in Florida and Texas. It also cites the proposed Medicaid Fiscal Accountability Rule and the fiscal 2021 budget proposal that includes $920 billion of Medicaid cuts over ten years, which the filing says could have a material adverse effect on operators.

  4. How is Omega funding its growth and dividends?

    In 2019 Omega issued $500 million of 3.625% senior notes due 2029, settled a forward equity sale of 7.5 million shares for about $295.9 million, issued $109.0 million through its equity shelf program, and raised $115.1 million through its dividend reinvestment plan. The company also borrowed about $350 million under its revolving credit facility to fund the MedEquities cash consideration and debt repayment.

  5. What legal matters could affect Omega?

    A securities class action was dismissed with prejudice in March 2019 and is on appeal to the Second Circuit, with oral argument held November 13, 2019. Shareholder derivative suits are stayed pending that appeal. The company also received a DOJ Civil Investigative Demand related to Lakeway Hospital, which MedEquities received in 2016; the company believes its conduct complied with applicable laws but cannot yet determine whether a loss is probable.